13.5 C
New York
Friday, April 26, 2024

New Wall Street Coverage: GoPro, Kraft Heinz And More

Courtesy of Benzinga.

Related
Benzinga's Top Initiations
Jefferies Initiates Axovant Sciences At Buy
According to analyst, Axovant's RVT-101 could be a blockbuster or maybe not (Seeking Alpha)

Related
Stifel Starts Biotie At Buy, Says Lead Product Can 'Meaningfully Improve' Parkinson's Patients
Benzinga's Top Initiations

A few stocks saw coverage initiation on Monday. Here's a recap in case you missed it.

Axovant Sciences Ltd (NYSE: AXON)

  • RBC Capital – Initiated with Outperform rating; $40 price target.
  • Jefferies Group – Buy rating; $31 price target.
  • Evercore Partners – Buy rating; $29 price target.

Biotie Therapies (NASDAQ: BITI)

  • Stifel Nicolaus – Initiated with Buy rating; $30 price target.
  • RBC Capital – Outperform rating; $35 price target.
  • JMP Securities – Outperform rating; $32 price target.

GoPro Inc (NASDAQ: GPRO)

  • Goldman Sachs – Initiated with Neutral rating; $60 price target.

Kraft Heinz Co (NASDAQ: KHC)

  • Credit Suisse – Initiated with Outperform rating; $85 price target.

Latest Ratings for AXON

Date Firm Action From To
Jul 2015 Jefferies Initiates Coverage on Buy
Jul 2015 RBC Capital Initiates Coverage on Outperform
Jul 2015 Evercore Partners Initiates Coverage on Buy

View More Analyst Ratings for AXON
View the Latest Analyst Ratings

Posted-In: Price Target Initiation Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,319FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x